What is the current share price of undefined today on both NSE and BSE?

undefined shares are currently priced at ₹undefined on NSE and ₹undefined on BSE as of undefined. Please be aware that stock prices are subject to continuous fluctuations due to various factors.

How has undefined [undefined] share performed in the past?

The past 1-year return of undefined RIL share was undefined%. The undefined [undefined] share hit a 1-year low of Rs. undefined and a 1-year high of Rs. undefined.

What is the market cap of undefined [undefined]?

The market cap of undefined is ₹undefined Cr as of undefined.

What is the current P/E ratio of undefined [undefined] share price?

The PE ratios of undefined is undefined as of undefined.

What is the current PB ratio of undefined [undefined] share price?

The PB ratios of undefined is undefined as of undefined

How can I buy undefined RIL shares?

You can easily buy undefined shares in Kotak Securities by opening a free demat account and getting the KYC documents verified online.

Alembic Pharmaceuticals Ltd Financials Statements: Check Balance Sheet and Cash Flow

Products
Investment Suite
Stocks
Mutual Funds
Future and Options
IPO
Exchange Traded Funds
Commodity
Stockcase (Stock Baskets)
Currency
Non Convertible Debentures
Sovereign Gold Bond
Exclusive
NRI Account
Corporate/HUF Trading Account
Private Client Group
Features
SipIt
MTF
Investment Suite

Exclusive

Features
Platform
Trading Platforms
Kotak Neo App & Web
Nest Trading Terminal
NEO Trade APIs
Features and Tools
MTF
Securities Accepted as Collateral
Margin Requirements
Equity Screeners
Payoff Analyzer
Calculators
SIP Calculator
Lumpsum Calculator
Brokerage Calculator
Margin Calculator
MTF Calculator
SWP Calculator
CAGR Calculator
Simple Interest Calculator
ELSS Calculator
Step up SIP Calculator

All Calculators
Trading Platforms

Features and Tools

Calculators

Research
Research Calls
Long Term calls
Short Term calls
Intraday calls
Derivatives calls
Pick of the week
Top Monthly Picks
Research Reports
Fundamental Research Report
Technical Research Report
Derivative Research Report
Research Calls

Research Reports
Market
Stocks
Share Market Today
Large Cap
Mid Cap
Small Cap
Indices
Nifty 50
Bank Nifty
FinNifty
Nifty Midcap India
VIX

All Indian Indices
Mutual Funds
SBI Mutual Funds
HDFC Mutual Funds
Axis Mutual Funds
ICICI Prudential Mutual Funds
Nippon India Mutual Funds

All AMC's
IPO
Upcoming IPO
Current IPO
Closed IPO
Recently Listed IPO
Stocks

Indices

Mutual Funds

IPO
Learn
Stockshaala
Basics of Stock Market
Introduction to Fundamental Analysis
Introduction to Technical Analysis
Derivatives, Risk management & Option Trading Strategies
Personal Finance
Resource
Market Ready
Kotak Insights
Infographic
Podcast
Webinars
Youtube Channel
Quarterly Results
Investing Guide
Demat Account
Trading Account
Share Market
Intraday Trading
IPO
Mutual Funds
Events
Budget 2025
Muhurat Trading
Share Market Holiday
Market Outlook 2025
Stockshaala

Resource

Investing Guide

Events
Partner
Business Associates
Kotak Connect Plus
Startup connect
Support
FAQs
Circulars
Bulletins
Contact Us
Forms Download
Get your Statement

Search stocks

Open Demat Account

Products

Platform

Pricing

Research

Market

Stocks

Share Market Today

Large Cap

Mid Cap

Small Cap

State Bank of India

Reliance Industries Ltd

HDFC Bank Ltd

Infosys Ltd

Tata Consultancy Services Ltd

Hindustan Unilever Ltd

ITC Ltd

IRCTC

Indices

NSE

Nifty 50

Bank Nifty

FinNifty

Nifty Midcap India

VIX

All Indian Indices

BSE

Sensex

BSE Bankex

BSE Small Cap

BSE Mid Cap

BSE 100

Mutual Funds

AMC's

SBI Mutual Funds

HDFC Mutual Funds

Axis Mutual Funds

ICICI Prudential Mutual Funds

Nippon India Mutual Funds

All AMC's

Schemes

Parag Parikh Flexi Cap

SBI Small Cap Fund

SBI Contra Fund

Nippon Small Cap Fund

ICICI Pru Technology Fund

IPO

Upcoming IPO

Current IPO

Closed IPO

Recently Listed IPO

Learn

Partner

Support

Open Demat Account

Home > Alembic Pharmaceuticals Ltd > Key Financials

Consolidate

Standalone

Financial Year	Mar '25	Dec '24	Sep '24	Jun '24	Mar '24
Total Qtr Revenue cr	1,783.83	1,702.24	1,664.72	1,563.83	1,520.58
Other Income Qtr Cr	14.19	9.50	16.74	2.10	3.60
Operating Revenues Qtr	1,769.64	1,692.74	1,647.98	1,561.73	1,516.98
*All values are in Cr.
Operating Expenses Qtr	1,497.71	1,432.52	1,408.71	1,324.90	1,256.92
Operating Profit Qtr	271.93	260.22	239.27	236.83	260.06
EBITDA Qtr Cr	286.12	269.72	268.88	238.93	263.66
Depreciation Qtr	68.99	70.04	70.51	69.04	69.48
Net Profit Qtr	156.89	138.42	153.40	134.71	178.21
Basic EPS Qtr	7.98	7.01	7.79	6.85	9.07

Open Demat Account

Download App

Open Account